Debunking Constipation Myths: What Community Pharmacists Need to Know

Constipation is a highly prevalent gastrointestinal disorder that significantly impacts quality of life and is associated with a substantial healthcare burden. Despite advances in its clinical understanding, its management remains hindered by the persistence of myths and unfounded beliefs that compromise appropriate treatment and obstruct effective healthcare intervention. This study aims to identify, analyze, and clarify some of the most frequent misconceptions surrounding constipation, providing community pharmacists with an evidence-based tool to enhance their clinical and educational practice. A narrative review of the scientific literature published between 2015 and 2025 was conducted, drawing from biomedical databases (PubMed, ScienceDirect, Cochrane) and institutional sources. Selected materials included articles, clinical guidelines, and consensus documents focused on myths related to the pathophysiology, treatment, and prevention of constipation. Among the most prevalent misconceptions are: the necessity of daily bowel movements, the effectiveness of increased fluid intake or olive oil on an empty stomach, the alleged harmfulness or addictive potential of laxatives, the belief that affects only women, and its supposed direct link to colorectal cancer. Misunderstandings regarding the role of dietary fiber, probiotics, and specific foods were also explored. The findings reveal a significant discrepancy between popular beliefs and current scientific knowledge. It is concluded that community pharmacists, as first-line healthcare providers, must play an active role in dispelling misconceptions about constipation through rigorous, evidence-based, and personalized patient education.